Back to mobile site

Form 8-K CLOROX CO /DE/ For: Jun 14

June 17, 2026 4:16 PM EDT
false 0000021076 0000021076 2026-06-14 2026-06-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 14, 2026

 

 

THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)

 

     
Delaware 1-07151 31-0595760
(State or other jurisdiction of incorporation) (Commission File Number)

(I.R.S. Employer
Identification No.)

 

1221 Broadway, Oakland, California 94612-1888
(Address of principal executive offices) (Zip code)

 

(510) 271-7000

(Registrant’s telephone number, including area code)

 

Not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock - $1.00 par value CLX New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On June 14, 2026, the Management Development and Compensation Committee (the “MDCC”) of the Board of Directors of The Clorox Company (the “Company”) appointed Chris Hyder, age 51, to be Executive Vice President and Chief Operating Officer (“COO”) effective June 17, 2026. Information on Mr. Hyder’s previous roles can be found in our Annual Report on Form 10-K for the fiscal year ended June 30, 2025 filed with the SEC on August 8, 2025 (the “2025 10-K”) and is hereby incorporated into this Item 5.02.

 

In connection with Mr. Hyder’s appointment, on June 14, 2026, the MDCC approved an increase in Mr. Hyder’s base salary to $800,000 and an increase in his short-term incentive target from 90% to 100% of his salary, effective as of June 17, 2026. In addition, on June 17, 2026, Mr. Hyder will receive a grant of restricted stock units that have an aggregate fair value of $4,000,000, which will vest in three years.

 

Also on June 14, 2026, Nina Barton, formerly Executive Vice President and Group President – Care & Connection, was appointed Executive Vice President and Chief Growth & Strategy Officer, effective June 17, 2026. Information on Ms. Barton’s previous roles can be found in our 2025 10-K and is hereby incorporated into this Item 5.02.

 

Neither Mr. Hyder nor Ms. Barton has any familial relationships nor related party transactions with the Company that would require disclosure under Items 401(d) or 404(a) of Regulation S-K (17 CFR 229.401(d) and 229.404(a)) in connection with his or her appointment described above.

 

Item 7.01 Regulation FD Disclosure.

 

A copy of the press release announcing these developments is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits 

 

(d) Exhibits

 

See the Exhibit Index below, which is incorporated by reference herein.

 

EXHIBIT INDEX

 

Exhibit Description
   
99.1 The Clorox Company Press Release dated June 17, 2026
   
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  THE CLOROX COMPANY
   
Date:  June 17, 2026 By:  /s/ Angela Hilt
    Angela Hilt
    Executive Vice President and Chief Legal and
    External Affairs Officer & Corporate Secretary

 

 

 

ATTACHMENTS / EXHIBITS

THE CLOROX COMPANY PRESS RELEASE DATED JUNE 17, 2026

XBRL TAXONOMY EXTENSION SCHEMA

XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

XBRL TAXONOMY EXTENSION LABEL LINKBASE

IDEA: R1.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: clx4653041-8k_htm.xml



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings